Novo Nordisk cuts prices on its weight-loss drugs
The move lowers out-of-pocket costs for patients paying cash, and sharpens price competition in the incretin market.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 3 02:52 ETSource: bworldonline.com
The wire
- 01Novo Nordisk is reducing prices on its weight-loss medicines, according to the report.
- 02Cash-pay pricing shapes where telehealth operators and patients source semaglutide, and narrows the gap with compounded alternatives.
- 03Specific dose-level prices, effective dates and channel terms are not detailed in the report; watch for company confirmation.
From the source
Read at bworldonline.comnovo nordisk is cutting prices on its weight loss drugs
